Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2020 Jan 30;160(4):1064–1073. doi: 10.1016/j.jtcvs.2019.12.115

TABLE 2.

Characteristics of patients who experienced major postoperative bleeding and other hematologic complications

Patient Age, y Gender Histology Caprini score VTE HIT Event on index admission or readmission Major bleeding event Major bleeding days postoperatively Bleeding related to AC IVC filter Long-term treatment
1 77 Male Biphasic 9 RIJ, LIJ, axillary, subclavian DVTs right upper and lower lobe segmental, right middle lobe subsegmental PEs No Index admission Yes, hemothorax 1 No Yes, postoperative Warfarin
2 67 Male Biphasic 12 Yes, right popliteal, left soleal DVTs No Index admission Yes, hemothorax 18 Yes, 7 d after AC Yes, postoperative Apixaban
3 62 Female Biphasic 12 Yes, LIJ DVT No Readmission Yes, Hemothorax 18 Yes, 13 d after AC No Enoxaparin
4 71 Male Biphasic 12 No No Index admission DIC 0 No No *
5 72 Female Epithelioid 11 No No Index admission Yes, hemothorax 16 No No -
6 73 Male Biphasic 11 No Yes Index admission Yes, hemothorax 1 No No -
7 78 Male Epithelioid 12 No Yes Index admission Yes, hemoptysis, hematuria 3 No No -
8 64 Female Epithelioid 12 No Yes Index admission No - No No -
9 68 Male Epithelioid 10 Yes, LIJ, subclavian, axillary, soleal DVTs; right upper and lower lobe segmental and subsegmental PEs. Yes Index admission No - No No *

VTE, Venous thromboembolism; HIT, heparin-induced thrombocytopenia; AC, anticoagulation; IVC, inferior vena cava; RIJ, right internal jugular; LIJ, left internal jugular; DVT, deep vein thrombosis; PE, pulmonary embolus; DIC, disseminated intravascular coagulation.

*

Perioperative mortality, not related to VTE.